Your institution may have access to this item. Find your institution then sign in to continue.
Title
Balancing the risks and benefits of prophylaxis: a reply to ' Pneumocystis jiroveci pneumonia in patients treated with systemic immunosuppressive agents for dermatologic conditions'.
A letter to the editor is presented in response to the article "Pneumocystis Jiroveci Pneumonia in Patients Treated With Systemic Immunosuppressive Agents for Dermatologic Conditions: A Systematic Review With Recommendations for Prophylaxis" that was published in a 2016 issue.